Table 3. Overall analysis of miR-193b expression associated with clinicopathological characteristics.
| Clinicopathological parameters | No. of studies | No. of patients | Pooled OR (95% CI) | Heterogeneity | |||
|---|---|---|---|---|---|---|---|
| Fixed | Random | I2 | P value | ||||
| Gender (male vs. female) | 5 | 536 | 0.98 (0.69, 1.40) | 1.00 (0.62, 1.61) | 35.50% | 0.184 | |
| Age (≤64.5 vs. >64.5 years) | 2 | 153 | 0.92 (0.49, 1.75) | 0.91 (0.46, 1.82) | 11.30% | 0.288 | |
| Tumor size (≤5 vs. >5 cm) | 3 | 312 | 2.36 (1.48, 3.76) | 2.36 (1.48, 3.76) | 0.00% | 0.965 | |
| Lymph node metastasis (absent vs. present) | 4 | 359 | 3.16 (2.02, 4.93) | 3.16 (2.02, 4.93) | 0.00% | 0.987 | |
| Distant metastasis (absent vs. present) | 5 | 491 | 3.59 (2.12, 6.09) | 3.52 (2.07, 6.00) | 0.00% | 0.932 | |
95% CI, 95% confidence interval; Fixed, fixed model; OR, odds ratio; Random, random model.